why choose us

First received: May 15, 2023

Clinical Trial: Prospective, Randomized Controlled Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Kidney Transplant Rejection

Study Type: INTERVENTIONAL


Official Title: Prospective, Randomized Controlled Trial to Investigate Additional Interventional Telemedical Management Versus Standard Aftercare in Kidney Transplant Recipients (smartNTx)

Brief Summary: The smartNTx trial: Prospective, randomized controlled trial (RCT) to investigate additional interventional telemedical management versus standard aftercare in kidney transplant recipients (KTR).STUDY PURPOSE: To demonstrate that additional interventional telemedical management will lead to a higher chance for long-term graft survival, increase adherence, quality of life (QoL), and reduce complications and healthcare costs after kidney transplantation.

Read more